Biological Technologies HR001124S0034
Summary
AI-generated · Sep 09, 2025Seeks revolutionary research ideas for topics not addressed by ongoing BTO programs or other published solicitations. This amendment to the Biological Technologies Office’s Office-Wide Broad Agency Announcement introduces an accelerated award option, defines the classified submissions process, announces the use of Special Notices for targeted studies, and clarifies eligibility for Federally Funded Research and Development Centers and University-Affiliated Research Centers.
Proposers are encouraged to submit a proposal abstract and await feedback before submitting a full proposal; if an abstract is favorably received, a follow-on full proposal may be invited under a subsequent solicitation. Deadlines have been extended, and a similarly scoped funding opportunity is expected to be published soon after the current one closes.
Note: Submission deadlines have been extended to October 9, 2024. We anticipate the publication of a similarly scoped funding opportunity immediately following the expiration of HR001124S0034. If a proposal abstract was submitted at/near the deadline and favorably received, the follow-on full proposal could be submitted in response to the new solicitation. For this reason, we still *STRONGLY* encourage submitting a proposal abstract and awaiting feedback prior to the submission of a full proposal, even as the deadline nears. This announcement seeks revolutionary research ideas for topics not being addressed by ongoing BTO programs or other published solicitations. The purpose of Amendment 1 to HR001123S0045, Biological Technologies, the Biological Technologies Office s Office-Wide Broad Agency Announcement, is to introduce an accelerated award option, define the classified submissions process, announce the use of Special Notices (SNs) for targeted studies, and clarify the eligibility of Federally Funded Research and Development Centers (FFRDCs) and University-Affiliated Research Centers (UARCs).
From Solicitation posted on Sep 08, 2025The purpose of Amendment 3 to HR001124S0034, Biological Technologies, the Biological Technologies Office s Office-Wide Broad Agency Announcement, is to close the solicitation as it has been replaced with HR001126S0003. Thew new solicitation can be found at the URL below: https://sam.gov/opp/8d403582edfd409795560247e8d229b7/view
From Solicitation posted on Oct 01, 2025This contract is fixed price and awarded competitively.
From Award Notice posted on Oct 21, 2025Notice history
3-
Solicitation Posted Sep 08, 2025
-
Solicitation Posted Oct 01, 2025View changes (2)
- Description: Description was updated
- Response Deadline: Oct 09, 2025 → Sep 30, 2025
-
Award Notice LATEST Posted Oct 21, 2025
Details
Award Information
Award Notices
Posted: Oct 21, 2025
This contract is fixed price and awarded competitively.
Awardees
| Company Name | UEI | CAGE Code | Location |
|---|---|---|---|
| The Council on Strategic Risks | N/A | N/A | Washington, DC |